Further immunohistochemical analysis revealed that the tumor was positive for CD43, lysozyme, and myeloperoxidase but negative for CD3, CD20, and CD30, supporting the diagnosis of myeloid sarcoma. This evidence concerns the gene MPO and myeloid sarcoma.